To further assess the significance of our findings for ischemic heart disease, we quantified the plasma concentrations of MIF-2 in a large cohort of CAD patients and also compared ACS and CCS sub-groups as an indicator of disease severity. This evidence concerns the gene DDT and coronary artery disorder.